Free Trial

biote (BTMDW) Competitors

biote logo
$0.46 -0.01 (-2.12%)
(As of 12/17/2024 ET)

BTMDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BCTXW

Should you be buying biote stock or one of its competitors? The main competitors of biote include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

biote vs.

180 Life Sciences (NASDAQ:ATNFW) and biote (NASDAQ:BTMDW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

In the previous week, 180 Life Sciences' average media sentiment score of 1.87 beat biote's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
biote Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
biote N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
biote$193.06MN/AN/AN/AN/A

180 Life Sciences and biote both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
bioteN/AN/A

Summary

180 Life Sciences and biote tied by winning 1 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTMDW vs. The Competition

MetricbioteMedicinal Chemicals IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$2.17B$9.31B
Dividend YieldN/AN/A2.72%4.06%
P/E RatioN/AN/A25.4217.54
Price / SalesN/AN/A403.30139.37
Price / CashN/AN/A40.2237.95
Price / BookN/AN/A2.284.92
Net IncomeN/AN/A$165.18M$225.78M
7 Day Performance-1.60%-1.60%-0.84%-1.58%
1 Month Performance-71.27%-71.27%1.48%6.67%
1 Year Performance-58.71%-58.71%7.58%22.48%

biote Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTMDW
biote
N/A$0.46
-2.1%
N/AN/A$0.00$193.06M0.00N/AHigh Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
flat
N/A+4.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040Gap Up
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+12.9%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.7799 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+13.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004Gap Up
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
flat
N/A+263.0%$0.00$35.36M0.0070Positive News
BCTXW
BriaCell Therapeutics
N/A$0.35
-14.8%
N/A-80.9%$0.00N/A0.008

Related Companies and Tools


This page (NASDAQ:BTMDW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners